Tori Rodriguez, MA, LPC, AHC

Can energy be harvested from the body or environment and converted into electrical energy to replace or supplement batteries in cardiovascular devices?

Atherosclerotic cardiovascular disease represents the top global cause of morbidity and mortality.

The American Society of Hematology released evidence-based guidelines for the treatment of DVT and PE in patients without cancer.

Lipid-lowering therapies are key to the prevention of cardiovascular (CV) events and CV-related mortality.

Current guidelines recommend a 12-month-long DAPT to reduce the risk for ischemic and thrombotic events following percutaneous coronary intervention.

Patients with HFpEF have substantial exercise intolerance, which may be due to peripheral factors.

PAH associated with CHD is linked to significant reductions in survival and quality of life, especially for patients progressing to Eisenmenger syndrome.

Only 65.2% of adults surveyed in United States in 2014 reported that they consistently get at least 7 hours of sleep each night.

Individuals with CAD who have not experienced a recent CV event are generally considered to have stable CAD.

Although mortality rates associated with cardiovascular disease have decreased significantly in high-income countries in recent decades, substantial challenges related to CVD treatment and outcomes persist in rural areas.